A Phase II Trial of 18F-AV-45 Positron Emission Tomography (PET) Imaging in Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD)
This study has been completed.
Study NCT00702143
Information provided by Avid Radiopharmaceuticals
First Received on June 19, 2008.
Last Updated on May 8, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
